use of Asprin in Diabetes
PRESS RELEASE - Friday, 17th October 2008
Society Issues Advice to Members of the Public with Diabetes on the Dangers of Self-Medication
The Pharmaceutical Society of Northern Ireland has responded to research published in this morning's British Medical Journal which indicated there is little or no benefit in diabetes patients without symptoms of heart disease routinely taking aspirin as a means of preventing a heart attack.
Society President Raymond Anderson said:
"Today's research in the BMJ indicates that there is no benefit in diabetic patients taking aspirin as a primary preventative medication against cardiovascular disease, although we would look to see this research being replicated in other studies. This serves to reiterate the point that patients with diabetes should always seek expert advice from their pharmacist or GP before engaging in any form of self-medication.
All medicines carry risks and aspirin is no different. The benefits of a particular treatment must always be balanced against the risks. As with many available medications, misappropriate use can have serious consequences for personal health. This is particularly the case for patients with certain long-term conditions. Therefore we recommend patients, particularly those with conditions such as diabetes, discuss the long term use of over the counter medication with their community pharmacist or GPs."
Ends
For further information please contact Mark Neale, Head of Public Affairs at the Pharmaceutical Society of Northern Ireland, on 02890 267932 or 07854 004884
Editor's notes
- 1. The BMJ research is available here: